The Global Cancer Vaccines Market Is Witnessing High Growth Owing To the Increasing Developments by Key Players in the World
Cancer Vaccines |
Cancer Vaccines Market,
By Type (Preventive and Therapeutic), By Technology (Subunit Vaccines, Live
Attenuated Vaccines, and Others), and By Application (Cervical Cancer, Prostate
Cancer, and Others) - Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2022-2028.
Market Overview:
The
cancer vaccine is a type of therapy that aims to boost the body's immune system
to fight cancer. Several different kinds of vaccines are currently being
developed. Some use a single antigen, while others target a large variety of
antigens. Developing a cancer vaccine is a difficult task. However, researchers
are finding ways to improve its efficacy. Personalized vaccines are designed
for individual patients. This allows researchers to target more cancer-specific
antigens. They are also easier to produce than DNA-based vaccines. Unlike
conventional vaccines, mRNA-based vaccines are safe for people of all ages.
These vaccines are made from the patient's own tumor cells, which contain
cancer-specific antigens.
Competitive Landscape:
Major
players operating in the global Cancer
Vaccines Market include
Xiamen Innovax Biotech Co., Ltd., Organon Teknika Corp., LLC, Center of
Molecular Immunology, Serum Institute of India Pvt. Ltd., Biomed Lublin S.A.,
Walvax Biotechnology Co., Ltd., Dendreon Pharmaceuticals LLC., GSK plc, and
Merck & Co., Inc.
Key Market Drivers:
Increasing
developments by key market players in the global Cancer Vaccines Market are expected to augment the growth of the
market. For instance, in November 2021, Dendreon Pharmaceuticals LLC., and
Shoreline Biosciences announced a partnership alliance in order to research the
prospects of iPSC cellular therapy. The vaccine is given to a patient before
cancer develops. As the vaccine delivers the tumor-associated antigens, the
immune system responds to them. The strongest responses are associated with the
longest survival. Researchers believe that these responses help the immune
system recognize cancer. In addition, they could prevent cancer from developing
in the future. Moreover, the increasing incidence of cancer cases in the world
is estimated to enhance the growth of the global cancer vaccines market.
Covid-19 Impact Analysis:
During
the COVID-19 pandemic, there have been several developments in the global
cancer vaccines market. For instance, in June 2020, Walvax Biotechnology Co.,
Ltd. and Xiamen Innovax Biotech Co., Ltd. allied in order to supply enough
immunization for 84.0 million girls in Global Alliance for Vaccines and
Immunisation (Gavi) countries.
Key Takeaways:
· North
America is expected to dominate the growth of the global cancer vaccines
market, owing to the increasing prevalence of key players in the region. For
instance, in December 2020, Merck & Co., Inc. announced the construction of
a new manufacturing facility in order to higher its production of TICE Bacillus
Calmette–Guérin.
· The
Asia Pacific is estimated to witness high growth in the global cancer vaccines
market, owing to high developments done by key players in the region. For
instance, in August 2020, GSK Korea got indicated under Korea’s Monopoly
Regulation and Fair Trade laws relating to the government tenders focusing on
PCV (Synflorix) and HPV (Cervarix) vaccines.
Comments
Post a Comment